Drug reference

adrenochrome monosemicarbazone

Coagulant

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Not yet extracted

Indications

Reduce capillary fragilityControl oozing from raw surfacesPrevent microvessel bleeding (e.g., epistaxis, haematuria, secondary haemorrhage from wounds)

Dosing

Adult: 1–5 mg oral, i.m.

Related guidelines

GI bleeding on antiplatelet or anticoagulant therapy

CSI · Cardiology · 2020

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Abnormal uterine bleeding

FOGSI · Obstetrics & Gynaecology · 2016

Postpartum haemorrhage

FOGSI · Obstetrics & Gynaecology · 2024

Dyslipidaemia management

ICMR · Cardiology · 2023

Other Unclassified drugs

5-9-tetrahydrocannabinol

Ask House about adrenochrome monosemicarbazone

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Textbook-sourced·Sources: KD Tripathi 7e·Updated: 2026-05-10